AIG vs LCTX · P/E 21, rev $7.18B vs rev $9.5M
American International Group Inc (AIG) versus Lineage Cell Therapeutics Inc (LCTX) — a side-by-side from cached financials, not a winner call.
American International Group Inc (AIG) is a insurance - diversified company listed on US.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
Latest reported AIG revenue for 2024-12-31 was $7.18B. Net income was $901.0M. Revenue was up 6.3% from 2024-09-30 to 2024-12-31. AIG currently screens at market cap $48.97B and trailing P/E 20.6.
Latest reported LCTX revenue for 2024-12-31 was $9.5M. Net income was -$18.6M. Revenue was up 354.9% from 2023-12-31 to 2024-12-31. LCTX currently screens at market cap $213.6M.
AIG currently screens at market cap $48.97B and trailing P/E 20.6. LCTX currently screens at market cap $213.6M.
Not investment advice. Open the AIG and LCTX stock pages for the full models.
Not investment advice.